Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03360006
Title A Study Evaluating the Safety and Pharmacokinetics of ABBV-744 in Subjects With Advanced Prostate Cancer (CRPC) and Relapsed/Refractory Acute Myeloid Leukemia (AML) Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors AbbVie
Indications

acute myeloid leukemia

prostate cancer

Therapies

ABBV-744

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UC Irvine /ID# 160789 Orange California 92868 United States Details
University of California, Davis Comprehensive Cancer Center /ID# 202729 Sacramento California 95817 United States Details
Northwestern /ID# 171098 Chicago Illinois 60611 United States Details
University of Chicago DCAM /ID# 160702 Chicago Illinois 60637-1443 United States Details
Cleveland Clinic Main Campus /ID# 160756 Cleveland Ohio 44195 United States Details
University of Texas MD Anderson Cancer Center /ID# 160701 Houston Texas 77030 United States Details
Swedish-Center for Blood Disor /ID# 166487 Seattle Washington 98104 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field